Neuland Laboratories has announced to appoint Dr. Ravi Shankar Gopinath (DIN: 00803847) as an independent director of the company for a period of five years from August 1, 2025. The decision was taken through a postal ballot, the results of which were finalized on 31 July 2025.
The proposal to appoint Dr. Gopinath was passed by the members with the required majority through the remote e-voting process. According to the results of the postal ballot, the promoters and the promoter group had a total of 41,88,184 shares, of which 41,28,526 votes were cast, which is 98.576 percent of the outstanding shares. All the votes cast by this group were in favor of the proposal.
Public institutions had 41,56,423 shares, out of which 37,24,906 votes were cast, which is 89.62 percent of their outstanding shares. All the votes of public institutions were also in favor of the proposal.
Public non-institutions had 44,85,282 shares, of which 1,43,708 votes were cast, which is 3.20 percent of their outstanding shares. Of these, 1,43,469 votes were in favor and 239 votes were against the proposal.
In total, a total of 1,28,29,889 shares were included, of which 79,97,140 votes were cast, which is 62.33 percent of the total outstanding shares. There were 79,96,901 votes in favor, while 239 votes were against the proposal.
The duration of e-voting remained open from August 28, 2025 to 26 September, 2025. The votes were opened on 26 September 2025 in the presence of witnesses.
D. Hanumant Raju & Company, Company Secretaries investigated the e-voting process, and their report confirmed the results.
The results of the postal ballot indicate strong support for appointment of Dr. Ravi Shankar Gopinath as an independent director, with the proposal passed by a significant majority.
Confirmation register of e-votes related to remote e-voting will be assigned to Ms. Saradi Bhamidipati, Company Secretary and Compliance Officer for safe custody, who have been authorized by the company’s executive chairman to complete the necessary formalities in this regard.